Home > List All Publishers > Global Markets Direct

Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.

Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.

List of reports from Global Markets Direct

Bone Fracture – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture. Bone Fracture - Pipeline Review, Half Year ... \| read more...	$2,000.00
Rubella – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rubella. Rubella - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Tinnitus – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tinnitus. Tinnitus - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Vascular Dysfunction – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Vascular Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vascular Dysfunction. Vascular Dysfunction - Pipeline Review, Half Year ... \| read more...	$2,000.00
GlaxoSmithKline plc – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, GlaxoSmithKline plc’s corporate ... \| read more...	$1,500.00
Pfizer Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pfizer Inc.’s corporate ... \| read more...	$1,500.00
Bristol-Myers Squibb Company – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Amgen Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Amgen Inc.’s corporate ... \| read more...	$1,500.00
F. Hoffmann-La Roche Ltd. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00
Paladin Labs Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Access Pharmaceuticals, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Nymox Pharmaceutical Corporation – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
MethylGene Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MethylGene Inc.’s corporate ... \| read more...	$1,500.00
Northwest Biotherapeutics, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
3SBio Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, 3SBio Inc.’s corporate ... \| read more...	$1,500.00
Bionor Pharma ASA – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
ArQule, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ArQule, Inc.’s corporate ... \| read more...	$1,500.00
Bausch & Lomb Incorporated – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00
Acrux Limited – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Acrux Limited’s corporate ... \| read more...	$1,500.00
Sunovion Pharmaceuticals Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
EntreMed, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, EntreMed, Inc.’s corporate ... \| read more...	$1,500.00
Biotest AG – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Biotest AG’s corporate ... \| read more...	$1,500.00
Healthpoint Biotherapeutics – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Healthpoint Biotherapeutics’s corporate ... \| read more...	$1,500.00
Geron Corporation – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Geron Corporation’s corporate ... \| read more...	$1,500.00

< prev 4 5 6 7 8 9 10 11 12 13 next >